MGRX
Mangoceuticals, Inc.Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from date of issuance of this filing.”View the 10-Q filed May 19, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-03-16 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025. Represents Mr. Cohen's direct ownership of the Issuer. |
Stock Option (right to buy)
|
50,000 |
| 2026-03-16 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025. Represents Mr. Cohen's direct ownership of the Issuer. |
Stock Option (right to buy)
|
50,000 |
| 2026-03-16 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. The options vest over 18 months with 500,000 of the options vesting upon grant on September 9, 2025, and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company. Represents Mr. Cohen's direct ownership of the Issuer. |
Stock Option (right to buy)
|
2,000,000 |
| 2026-03-16 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. Represents Mr. Cohen's direct ownership of the Issuer. |
Stock Option (right to buy)
|
83,333 |
| 2026-03-16 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Other↓
Filing footnotes — Stock Option (right to buy) (Direct)
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. Represents Mr. Cohen's direct ownership of the Issuer. |
Stock Option (right to buy)
|
83,333 |
| 2026-03-16 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. The options vest over 18 months with 500,000 of the options vesting upon grant on September 9, 2025, and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company. Represents Mr. Cohen's direct ownership of the Issuer. |
Stock Option (right to buy)
|
2,000,000 |
| 2025-12-15 | JOHNSTON EUGENE M |
CFO |
Sell↓
|
Common Stock
|
3,333 |
| 2025-12-09 | JOHNSTON EUGENE M |
CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.19 to $1.21, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
5,000 |
| 2025-12-05 | JOHNSTON EUGENE M |
CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.10 to $1.20, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
10,000 |
| 2025-11-19 | Hamilton Alex P. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $1.195 to $1.2465, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
125,000 |
| 2025-09-09 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. The options vest over 18 months with 500,000 of the options vesting upon grant and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company. Represents Mr. Cohen's direct ownership of the Issuer. |
Stock Option (right to buy)
|
2,000,000 |
| 2025-09-09 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Represents Mr. Cohen's direct ownership of the Issuer. |
Common Stock
|
500,000 |
| 2025-09-09 | Hamilton Alex P. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2025-09-09 | JOHNSTON EUGENE M |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2025-09-09 | MYERS KENNY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2025-09-09 | D'Alessio Lorraine Pamela |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2025-07-21 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Warrant to Purchase Common Stock (Direct)
On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company. Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein. |
Warrant to Purchase Common Stock
|
50,000 |
| 2025-07-21 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Convertible Promissory Note (Direct)
On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company. Represents the maturity date of the Convertible Promissory Note. Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein. |
Convertible Promissory Note
|
0 |
| 2025-06-05 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Gift↑
Filing footnotes — Common Stock (Direct)
Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein. |
Common Stock
|
200,000 |
| 2025-06-05 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Gift↓
Filing footnotes — Common Stock (Direct)
Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. Represents Mr. Cohen's direct ownership of the Issuer. |
Common Stock
|
200,000 |
| 2025-04-10 | Hamilton Alex P. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
25,000 |
| 2025-04-10 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Represents Mr. Cohen's direct ownership of the Issuer. |
Common Stock
|
200,000 |
| 2025-04-10 | Isaac Antonios |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as President of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
60,000 |
| 2025-04-10 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Represents Mr. Cohen's direct ownership of the Issuer. |
Common Stock
|
200,000 |
| 2025-04-10 | D'Alessio Lorraine Pamela |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
25,000 |
| 2025-04-10 | MYERS KENNY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a discretionary bonus in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
25,000 |
| 2024-11-11 | JOHNSTON EUGENE M |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan, as amended. Exempt pursuant to Rule 16b-3. |
Common Stock
|
25,000 |
| 2024-08-26 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Gift↓
Filing footnotes — Common Stock (Direct)
Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. Represents Mr. Cohen's direct ownership of the Issuer. |
Common Stock
|
800,000 |
| 2024-08-26 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Gift↑
Filing footnotes — Common Stock (Direct)
Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. |
Common Stock
|
800,000 |
| 2024-06-26 | Hamilton Alex P. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $0.33 to $0.32, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
108,426 |
| 2024-06-25 | Hamilton Alex P. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $0.32 to $0.31, inclusive. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
Common Stock
|
16,574 |
| 2024-06-03 | Hamilton Alex P. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2024-06-03 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a bonus for fiscal 2024 for compensation as an officer of the Company. Granted under the Registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. Held directly by Mr. Cohen. |
Common Stock
|
800,000 |
| 2024-06-03 | Hammer Amanda Elizabeth |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Issued in consideration for services rendered as Chief Operating Officer. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2024-06-03 | D'Alessio Lorraine Pamela |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2024-06-03 | MYERS KENNY |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Issued in consideration for services rendered as a member of the Board of Directors. Issued under the registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
100,000 |
| 2023-12-28 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
Granted in consideration for services rendered as an officer of the Registrant. Granted under the Registrant's 2022 Equity Incentive Plan. Held directly by Mr. Cohen. |
Stock Option (right to buy)
|
125,000 |
| 2023-10-03 | JOHNSTON EUGENE M |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Issued in consideration for serving as Chief Financial Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
50,000 |
| 2023-05-01 | Hammer Amanda Elizabeth |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Issued as a sign-on bonus for agreeing to become the Chief Operating Officer of the Issuer. Issued under the registrant's 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. |
Common Stock
|
75,000 |
| 2023-05-01 | Hammer Amanda Elizabeth |
Chief Operating Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2022 Equity Incentive Plan in consideration for services to be rendered as Chief Operating Officer. Granted under the registrant's 2022 Equity Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3. The options vest at the rate of 1/3rd of such options on each of May 1, 2024, 2025 and 2026, subject to the Reporting Person's continued service to the Company on such vesting dates. |
Stock Option (Right to Buy)
|
150,000 |
| 2023-04-10 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Direct)
Shares acquired in a private transaction. Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. |
Common Stock
|
275,000 |
| 2023-04-04 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Gift↓
Filing footnotes — Common Stock (Indirect)
Represents the transfer of shares from Cohen Enterprises, Inc. which entity Mr. Jacob D. Cohen beneficially owns, to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. The shares are held in the name of Cohen Enterprises, Inc, which entity Mr. Cohen controls and which shares he is deemed to beneficially own. |
Common Stock
(I)
|
8,000,000 |
| 2023-04-04 | Cohen Jacob D. |
Director, Chief Executive Officer, 10% Owner |
Gift↑
Filing footnotes — Common Stock (Direct)
Represents the transfer of shares from Cohen Enterprises, Inc. which entity Mr. Jacob D. Cohen beneficially owns, to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. |
Common Stock
|
8,000,000 |